𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib

✍ Scribed by S. Emanuele; M. Lauricella; D. Carlisi; B. Vassallo; A. D’Anneo; P. Di Fazio; R. Vento; G. Tesoriere

Publisher
Springer
Year
2007
Tongue
English
Weight
627 KB
Volume
12
Category
Article
ISSN
1360-8185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Bcl-xL inhibitor, ABT-737, efficient
The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib
✍ Hayato Hikita; Tetsuo Takehara; Satoshi Shimizu; Takahiro Kodama; Minoru Shigeka 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 703 KB

Tumor cells are characterized by uncontrolled proliferation, often driven by activation of oncogenes, and apoptosis resistance. The oncogenic kinase inhibitor sorafenib can significantly prolong median survival of patients with advanced hepatocellular carcinoma (HCC), although the response is diseas

Lactacystin, a specific inhibitor of the
Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells
✍ Laura A. Pasquini; Marcos Besio Moreno; Ana M. Adamo; Juana M. Pasquini; Eduardo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 2 views

The multicatalytic protease complex or proteasome is a fundamental nonlysosomal tool that the cell uses to process or degrade proteins at a fast rate through the ubiquitin and ATP-dependent proteolytic pathway. Examples of these important proteins include the tumor suppressor protein p53, various cy

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 1 views

## Abstract The article to which this erratum refers was published in J Cell Physiol (2008) 216: 698–707. © 2008 Wiley‐Liss, Inc. DOI: 10.1002/jcp.21444